Hexagon Capital Partners LLC
Source: SEC Form 13F · as of Mar 2026Hexagon Capital Partners LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $13.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$13.9M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 13,098 | $1.6M |
| PFEPFIZER INC | 54,618 | $1.5M |
| ABBVAbbVie Inc. | 7,025 | $1.5M |
| PMPhilip Morris International Inc | 8,650 | $1.4M |
| JNJJOHNSON & JOHNSON | 4,906 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 17,151 | $1.0M |
| LLYELI LILLY & Co | 1,107 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 6,747 | $940K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,955 | $800K |
| NVSNovartis AG | 3,783 | $578K |
| GMOptec International, Inc. | 5,768 | $430K |
| AMGNAMGEN INC | 1,171 | $412K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 6,161 | $340K |
| ABTABBOTT LABORATORIES | 3,223 | $331K |
| NVONovo Nordisk A/S | 7,342 | $270K |
| AZNASTRAZENECA PLC | 1,209 | $238K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 11,027 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.